SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Madrigal Pharmaceuticals Q3 EPS $(1.39) Down From $(0.56) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(1.39) per share. This is a 148.21 percent decrease over losses of $(0.56) per share from the same period last year.

Benzinga · -

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(1.39) per share. This is a 148.21 percent decrease over losses of $(0.56) per share from the same period last year.